Poseida Therapeutics Inc
(PSTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44,472 | 81,378 | 206,325 | 83,966 | 87,784 |
| Marketable Securities | 167,730 | 201,115 | 0 | 225,186 | 37,534 |
| Receivables | 9,010 | 9,088 | N/A | N/A | N/A |
| TOTAL | $226,475 | $298,563 | $213,873 | $313,996 | $127,179 |
| Non-Current Assets | |||||
| PPE Net | 19,055 | 21,586 | 22,050 | 23,336 | 10,858 |
| Intangibles | 5,548 | 5,548 | 5,548 | 5,548 | 5,548 |
| Other Non-Current Assets | 22,807 | 26,140 | 27,838 | 28,604 | 3,411 |
| TOTAL | $47,410 | $53,274 | $55,436 | $57,488 | $19,817 |
| Total Assets | $273,885 | $351,837 | $269,309 | $371,484 | $146,996 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 3,000 |
| Accounts payable and accrued liabilities | 3,267 | 2,228 | 8,961 | 763 | 4,929 |
| Accrued Expenses | 31,092 | 26,068 | 23,540 | 24,454 | 13,926 |
| TOTAL | $71,318 | $53,885 | $43,335 | $30,025 | $21,855 |
| Non-Current Liabilities | |||||
| Long Term Debt | 58,590 | 58,250 | 29,357 | 29,133 | 26,140 |
| Deferred Revenues | 31,008 | 19,723 | 4,497 | N/A | N/A |
| Other Non-Current Liabilities | 23,496 | 30,774 | 31,086 | 50,303 | 26,284 |
| TOTAL | $98,866 | $110,357 | $69,763 | $79,491 | $52,479 |
| Total Liabilities | $170,184 | $164,242 | $113,098 | $109,516 | $74,334 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 96,489 | 86,527 | 62,547 | 62,108 | N/A |
| Common Shares | 10 | 9 | 6 | 6 | 2 |
| Retained earnings | -594,291 | -470,861 | -406,859 | -281,885 | -152,221 |
| Other shareholders' equity | 126 | -149 | 0 | 5 | 19 |
| TOTAL | $103,701 | $187,595 | $156,211 | $261,968 | $72,662 |
| Total Liabilities And Equity | $273,885 | $351,837 | $269,309 | $371,484 | $146,996 |